WHO ICTRP trial
Investigating the efficacy of high dose of glucocorticoid in patients with…
IRCT20080901001165N52 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20080901001165N52 |
|---|---|
| Public title | Investigating the efficacy of high dose of glucocorticoid in patients with moderate to severe pneumonia related to COVID-19 |
| Scientific title | Investigating the efficacy of high dose of glucocorticoid in patients with moderate to severe pneumonia related to COVID-19 |
| Primary sponsor | Bagheiat-allah University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | COVID-19. Covid-19;U07.1 |
| Interventions | Intervention 1: Intervention group: At Day 1: Amp. Methylprednisolone 500mg IV infusion over 1 hour. At Day 2 and 3, Amp. Methylprednisolone 250mg IV infusion over 1 hour. At Day 4 and 5, Amp. Methylprednisolone100mg IV infusion over 1… |
| Registration date | May 5, 2020 |
| Target size | 50 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: